Whole Series Monkeypox Products
The World Health Organisation (WHO) declared the monkeypox outbreak a "public health emergency of international concern" for the second time on August 14, 2024. This highlighted and reinforced the global need for effective tools to combat the virus, encouraging increased efforts in research and development of vaccines, treatments, and diagnostic solutions.
To support researchers in their efforts to find solutions to this public health crisis, SanYou Bio has launched a comprehensive series of products aimed at supporting scientific investigations and advancing our understanding of monkeypox. These innovative tools are designed to address various aspects of research, including antibody screening, activity validation, and the development of potential therapeutic agents. SanYou Bio's product portfolio plays a vital role in enabling research that could lead to effective vaccines and treatments, assisting in mitigation and response of the outbreak.
As the official distributor of SanYou Bio’s monkeypox-related products, 2BScientific is dedicated to providing researchers with these essential reagents. The range of products available enables scientists to conduct in-depth studies, explore new possibilities of treatment, and enhance diagnostic capabilities. By equipping researchers with the tools necessary to investigate the monkeypox virus thoroughly, SanYou Bio and 2BScientific are aiming to contribute jointly to the global response to this urgent health threat.
SanYou Bio Monkey Pox Product Portfolio | ||
Product Name | Species | Type |
Mouse | Antibody | |
Alpaca | Antibody | |
Human | Antibody | |
Human | Antibody | |
Human | Antibody | |
Human | Antibody | |
Mouse | Antibody Pairs | |
Alpaca | Antibody Pairs | |
Human | Antibody Pairs | |
Human | Antibody Pairs | |
MPXV | Cell Line | |
MPXV | Recombinant protein | |
MPXV | Recombinant protein |
Through these collaborative efforts, the scientific community is better positioned to accelerate advancements in monkeypox research, ultimately leading to improved public health outcomes and a more effective response to future outbreaks. Listed below are some of the newest and most relevant products from SanYou Bio’s 65 monkeypox-related products, consisting of 11 cell lines, 26 antigens, and 28 monoclonal antibodies. These include coverage of A29L, M1R, H3L, E8L, A35R, and B6R, which are present on the surface of the monkeypox virus, as well as A28L, A30L, B21R, L1R, and I1L, which play roles in monkeypox virus infection and assembly.